Coexistence of anti-topoisomerase I and anticentromere antibodies in a patient with systemic sclerosis. Efficacy of treatment combining rituximab and nintedanib. A case report.
- DOI
- 10.1177/03946320221115310
- Published
- 2022 Jan-Dec
- Container
- International journal of immunopathology and pharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/03946320221115310,
title = {Coexistence of anti-topoisomerase I and anticentromere antibodies in a patient with systemic sclerosis. Efficacy of treatment combining rituximab and nintedanib. A case report.},
author = {Montolio-Chiva L and Carmona-Talavera D and López-Ortega JM and Orenes-Vera AV and Flores-Fernández E and Alegre-Sancho JJ},
year = {2022},
journal = {International journal of immunopathology and pharmacology},
doi = {10.1177/03946320221115310},
url = {https://doi.org/10.1177/03946320221115310}
}RIS
TY - JOUR TI - Coexistence of anti-topoisomerase I and anticentromere antibodies in a patient with systemic sclerosis. Efficacy of treatment combining rituximab and nintedanib. A case report. AU - Montolio-Chiva L AU - Carmona-Talavera D AU - López-Ortega JM AU - Orenes-Vera AV AU - Flores-Fernández E AU - Alegre-Sancho JJ PY - 2022 JO - International journal of immunopathology and pharmacology DO - 10.1177/03946320221115310 UR - https://doi.org/10.1177/03946320221115310 ER -
APA
L, M., D, C., JM, L., AV, O., E, F., & JJ, A. (2022). Coexistence of anti-topoisomerase I and anticentromere antibodies in a patient with systemic sclerosis. Efficacy of treatment combining rituximab and nintedanib. A case report.. International journal of immunopathology and pharmacology. https://doi.org/10.1177/03946320221115310
Source records
- pubmed · retrieved 2026-09-25T16:45:58.315Z
- europe-pmc · retrieved 2026-09-25T16:45:58.332Z
- doaj · retrieved 2026-09-25T16:45:58.328Z